These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11319230)

  • 1. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
    Chang JW; Mechling DE; Bächinger HP; Burrows GG
    J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, engineering and production of functional single-chain T cell receptor ligands.
    Burrows GG; Chang JW; Bächinger HP; Bourdette DN; Offner H; Vandenbark AA
    Protein Eng; 1999 Sep; 12(9):771-8. PubMed ID: 10506287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules.
    Nag B; Arimilli S; Mukku PV; Astafieva I
    J Biol Chem; 1996 Apr; 271(17):10413-8. PubMed ID: 8626615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein.
    Gauthier L; Smith KJ; Pyrdol J; Kalandadze A; Strominger JL; Wiley DC; Wucherpfennig KW
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11828-33. PubMed ID: 9751750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains.
    Arimilli S; Cardoso C; Mukku P; Baichwal V; Nag B
    J Biol Chem; 1995 Jan; 270(2):971-7. PubMed ID: 7529765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
    Wucherpfennig KW; Sette A; Southwood S; Oseroff C; Matsui M; Strominger JL; Hafler DA
    J Exp Med; 1994 Jan; 179(1):279-90. PubMed ID: 7505801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers.
    Kalandadze A; Galleno M; Foncerrada L; Strominger JL; Wucherpfennig KW
    J Biol Chem; 1996 Aug; 271(33):20156-62. PubMed ID: 8702739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2.
    Mukku PV; Passmore D; Phan D; Nag B
    Mol Immunol; 1995 Jun; 32(8):555-64. PubMed ID: 7541890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.
    Smith KJ; Pyrdol J; Gauthier L; Wiley DC; Wucherpfennig KW
    J Exp Med; 1998 Oct; 188(8):1511-20. PubMed ID: 9782128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
    Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG
    J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anergy induction by dimeric TCR ligands.
    Appel H; Seth NP; Gauthier L; Wucherpfennig KW
    J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes.
    Arimilli S; Mumm JB; Nag B
    Immunol Cell Biol; 1996 Feb; 74(1):96-104. PubMed ID: 8934660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.